NASDAQ
Apyx Medical Corporation (APYX) has a free cash flow growth of 77.47% as of Friday, May 29, 2026. This represents a 291.82% increase compared to its 12-month average of -40.39%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.